These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28375506)

  • 1. Moderator's view: Patient-centered approaches for optimizing AKI management: the role of kidney biomarkers.
    Mehta RL
    Nephrol Dial Transplant; 2017 Mar; 32(3):419-422. PubMed ID: 28375506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Con: Cautionary tales and reservations about the adoption of new technologies and biomarkers for the management of acute kidney injury.
    Van Biesen W
    Nephrol Dial Transplant; 2017 Mar; 32(3):414-417. PubMed ID: 28375504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for the optimal timing to start renal replacement therapy in critically ill patients with acute kidney injury.
    Bagshaw SM; Wald R
    Kidney Int; 2017 May; 91(5):1022-1032. PubMed ID: 28222898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption.
    Kashani K; Cheungpasitporn W; Ronco C
    Clin Chem Lab Med; 2017 Jul; 55(8):1074-1089. PubMed ID: 28076311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute kidney injury in 2013: Breaking barriers for biomarkers in AKI--progress at last.
    Cruz DN; Mehta RL
    Nat Rev Nephrol; 2014 Feb; 10(2):74-6. PubMed ID: 24375051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker-guided management of acute kidney injury.
    Kane-Gill SL; Meersch M; Bell M
    Curr Opin Crit Care; 2020 Dec; 26(6):556-562. PubMed ID: 33027146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of biomarkers to assess prognosis and guide management of patients with acute kidney injury.
    Cruz DN; Bagshaw SM; Maisel A; Lewington A; Thadhani R; Chakravarthi R; Murray PT; Mehta RL; Chawla LS
    Contrib Nephrol; 2013; 182():45-64. PubMed ID: 23689655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel biomarkers of AKI: the challenges of progress 'Amid the noise and the haste'.
    Bagshaw SM; Zappitelli M; Chawla LS
    Nephrol Dial Transplant; 2013 Feb; 28(2):235-8. PubMed ID: 23413276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in acute kidney injury (AKI).
    Teo SH; Endre ZH
    Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):331-344. PubMed ID: 29248140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intensive care medicine agenda on acute kidney injury.
    Pickkers P; Ostermann M; Joannidis M; Zarbock A; Hoste E; Bellomo R; Prowle J; Darmon M; Bonventre JV; Forni L; Bagshaw SM; Schetz M
    Intensive Care Med; 2017 Sep; 43(9):1198-1209. PubMed ID: 28138736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of Serum Creatinine and Kidney Injury Biomarkers for Diagnosing Histologic Acute Tubular Injury.
    Moledina DG; Hall IE; Thiessen-Philbrook H; Reese PP; Weng FL; Schröppel B; Doshi MD; Wilson FP; Coca SG; Parikh CR
    Am J Kidney Dis; 2017 Dec; 70(6):807-816. PubMed ID: 28844586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of drug-induced acute kidney injury in the adult.
    Gobe GC; Coombes JS; Fassett RG; Endre ZH
    Expert Opin Drug Metab Toxicol; 2015; 11(11):1683-94. PubMed ID: 26548752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute kidney injury in pediatric patients.
    Kwiatkowski DM; Sutherland SM
    Best Pract Res Clin Anaesthesiol; 2017 Sep; 31(3):427-439. PubMed ID: 29248148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro: Prevention of acute kidney injury: time for teamwork and new biomarkers.
    Ronco C; Rizo-Topete L; Serrano-Soto M; Kashani K
    Nephrol Dial Transplant; 2017 Mar; 32(3):408-413. PubMed ID: 28375502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Kidney Injury and Sepsis.
    Skube SJ; Katz SA; Chipman JG; Tignanelli CJ
    Surg Infect (Larchmt); 2018; 19(2):216-224. PubMed ID: 29304308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common chronic conditions do not affect performance of cell cycle arrest biomarkers for risk stratification of acute kidney injury.
    Heung M; Ortega LM; Chawla LS; Wunderink RG; Self WH; Koyner JL; Shi J; Kellum JA;
    Nephrol Dial Transplant; 2016 Oct; 31(10):1633-40. PubMed ID: 27342582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of new acute kidney injury biomarkers in human randomized controlled trials.
    Parikh CR; Moledina DG; Coca SG; Thiessen-Philbrook HR; Garg AX
    Kidney Int; 2016 Jun; 89(6):1372-9. PubMed ID: 27165835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of Clinical Trials in Acute Kidney Injury: Lessons from the Past and Future Directions.
    Weisbord SD; Palevsky PM
    Semin Nephrol; 2016 Jan; 36(1):42-52. PubMed ID: 27085734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Traditional and novel reference index for the withdrawal of renal replacement therapy in patients with acute kidney injury].
    Yang T; Han M; Su B
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):281-4. PubMed ID: 29919985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Worldwide Acute Kidney Injury, Renal Angina and Epidemiology in critically ill children (AWARE): study protocol for a prospective observational study.
    Basu RK; Kaddourah A; Terrell T; Mottes T; Arnold P; Jacobs J; Andringa J; Goldstein SL;
    BMC Nephrol; 2015 Feb; 16():24. PubMed ID: 25882434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.